ARTEMIS MED SERVICE
ARTEMISMED · NSE
297.95
-0.60 (-0.20%)
as of 29 Oct 2026 close
Open
297.00
High
301.35
Low
295.35
Prev close
298.55
52w high
378.80
25 Sept 2026
52w low
203.35
30 Mar 2026
VWAP
298.08
Delivery %
47.7%
of volume
Volume 90,594 · turnover ₹2.70 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 24 Jan 2020
- ISIN
- INE025R01021
- Series
- EQ
- Listed on NSE
- 23 Jan 2020
- Face value
- ₹1
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 30 Oct 2026, 06:30 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 306 |
| Other income | 8 |
| Total expenses | 273 |
| Operating margin | 17.7% |
| Finance costs | 7 |
| Depreciation | 14 |
| Profit before tax | 41 |
| Tax | 10 |
| Net profit | 31 |
| Net margin | 10.1% |
| EPS (₹) | 1.96 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison